ACLARION, INC. Prepaid Expense and Other Assets, Current
ACLARION, INC. (ACON) had Prepaid Expense and Other Assets, Current of $445.57 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Current $445.57K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $295.99K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $316.24K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $407.31K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $445.57K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $295.99K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $316.24K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $407.31K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $470.10K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $377.91K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $183.56K 10-K · filed 2026-03-18 | $342.29K 10-K · filed 2025-04-09 |
| 2024-09-30 | $558.27K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $649.36K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $378.46K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $245.03K 10-K · filed 2025-04-09 | |
| 2023-09-30 | $172.31K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $173.20K 10-Q · filed 2023-08-25 | |
| 2023-03-31 | $200.41K 10-Q · filed 2023-07-03 | |
| 2022-12-31 | $199.70K 10-K · filed 2024-03-28 | $195.53K 10-K · filed 2023-02-27 |
| 2022-09-30 | $188.31K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $581.45K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $492.51K 10-Q · filed 2022-06-06 | |
| 2021-12-31 | $273.39K 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |